{"product_id":"uscap-contemporary-issues-in-breast-pathology-2022","title":"USCAP Contemporary Issues in Breast Pathology 2022","description":"\u003cdiv aria-labelledby=\"\" class=\"--description panel\" id=\"\" role=\"tabpanel\"\u003e\n\u003cbr\u003e\u003cbr\u003e[\u003cbr\u003e\u003ch4\u003e\u003cstrong\u003eUSCAP Contemporary Issues in Breast Pathology 2022\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eUSCAP Contemporary Issues in Breast Pathology 2022 This course will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe course format will feature a combination of lectures, interactive microscopy sessions, and a digital slide review.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"single-main-content\"\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003ePracticing academic and community pathologists, and pathologists-in-training\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eUpon completion of this educational activity, learners will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDescribe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies\u003c\/li\u003e\n\u003cli\u003eDiscuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis\u003c\/li\u003e\n\u003cli\u003eDiscuss prognostic and predictive assays in patients with breast cancer\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eProgram : \u003c\/strong\u003e\n\u003cbr\u003e\u003ch4\u003e\u003cem\u003eItems Included in the Purchase of this Course\u003cbr\u003e\u003c\/em\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eInflammatory and Reactive Lesions, Contemporary Issues in Breast Core Needle Biopsies – Laura C. Collins, MD\u003c\/li\u003e\n\u003cli\u003eLow Grade Triple Negative Neoplasms \u0026amp; Classification and Management of LCIS – Stuart J. Schnitt, MD\u003c\/li\u003e\n\u003cli\u003eDiagnostic Agreement in Breast Pathology, Intraductal Proliferative Lesions, \u0026amp; Current Guidelines for ER, PR and – – HER2 Testing – Kimberly H. Allison, MD\u003c\/li\u003e\n\u003cli\u003eChallenging Fibroepithelial Lesions \u0026amp; Problematic Papillary Lesions – Edi Brogi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eNew Breast Cancer Prognostic and Predictive Factors \u0026amp; Spindle Cell Lesions – Ashley M. Cimino-Mathews, MD\u003c\/li\u003e\n\u003cli\u003ePathologic Evaluation of Specimens After Neoadjuvant Therapy \u0026amp; Mucinous Lesions – Hannah Y. Wen, MD, PhD\u003c\/li\u003e\n\u003cli\u003eDigital Slide Review with ARS – Laura C. Collins, MD and Stuart J. Schnitt, MD\u003c\/li\u003e\n\u003cli\u003ePanel Discussion and Q \u0026amp; A\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e]","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954355310690,"sku":"MED-AMB01883","price":80.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/image-1.jpg?v=1779374588","url":"https:\/\/meducourse.com\/products\/uscap-contemporary-issues-in-breast-pathology-2022","provider":"Meducourse","version":"1.0","type":"link"}